Jason Davis - 09 Jun 2025 Form 4 Insider Report for FibroBiologics, Inc. (FBLG)

Role: Chief Financial Officer
Signature: /s/ Ruben A. Garcia, by Power of Attorney
Issuer symbol: FBLG
Transactions as of: 09 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 10 Jun 2025, 16:03:24 UTC
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Davis Jason	Chief Financial Officer	C/O FIBROBIOLOGICS, INC., 455 E. MEDICAL CENTER BLVD., SUITE 300, HOUSTON,	/s/ Ruben A. Garcia, by Power of Attorney	10 Jun 2025	0001443533

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FBLG	Stock Option (Right to Buy)	Award	$0	+450,000		$0.000000	450,000	09 Jun 2025	Common Stock	450,000	$0.9448	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 9, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Content

On June 9, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.